4//SEC Filing
Zamirowski Justin 4
Accession 0000899243-22-018628
CIK 0001832415other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:12 PM ET
Size
7.4 KB
Accession
0000899243-22-018628
Insider Transaction Report
Form 4
Zamirowski Justin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-16$0.50/sh+35,236$17,618→ 35,236 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-16−35,236→ 45,303 totalExercise: $0.50Exp: 2030-08-13→ Common Stock (35,236 underlying)
Footnotes (1)
- [F1]The Assumed Option (as defined in the Agreement and Plan of Merger, dated April 6, 2021, as amended, by and among Mountain Crest Acquisition Corp. II, MCAD Merger Sub Inc. and Better Therapeutics, Inc.) vests as to 1/4th of the shares subject to the Assumed Option on July 27, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The Assumed Option was granted on August 14, 2020.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001888814
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:12 PM ET
- Size
- 7.4 KB